Liraglutide (Victoza) Liraglutide is a GLP-1 agonist
GHK-Cu (the parent compound AHK-Cu is derived from) has FDA approval for use in topical skincare formulations and has been studied extensively for tissue regeneration
Accessed September 19, 2023
This specialized combination incorporates growth hormone-releasing hormone (GHRH) analogues, selective ghrelin receptor agonists, and an insulin-like growth factor-1 (IGF-1) splice variant to investigate synergistic neuroendocrine signaling, metabolic flux, and tissue regeneration pathways
It regulates the production of decorin protein, which is essential for proper collagen fiber arrangement, leading to smoother, more even skin texture
B12, along with lipoplex and lipotropic injections, has been linked to rapid, safe weight loss